You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
北陸藥業(300016.SZ):2020年度淨利降48.98%至1.75億元 擬10派0.6元
格隆匯 03-18 20:04

格隆匯3月18日丨北陸藥業(300016.SZ)發佈2020年年度報吿,實現營業收入8.27億元,同比增長1.00%;歸屬於上市公司股東的淨利潤1.75億元,同比減少48.98%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.52億元,同比減少8.90%;基本每股收益0.36元;擬每10股派發現金紅利0.60元(含税)。

本報吿期,公司實現營業收入8.27億元,同比增長1.00%。母公司實現營業收入8.21億元,同比增長0.24%,基本持平,其中對比劑產品銷售收入6.39億元,同比下降3.70%;中樞神經類產品九味鎮心顆粒銷售收入1.13億元,同比增長63.35%;降糖類產品銷售收入7095.35萬元,同比下降19.02%。本期合併範圍變更,新增子公司海昌藥業納入合併報表範圍的營業收入624.79萬元

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account